Results 1 to 10 of about 37,432 (124)

Application of E-coach chronic disease management model in rehabilitation management of patients with arteriosclerosis obliterans [PDF]

open access: goldJournal of Health, Population and Nutrition, 2023
Objective To explore the effect of a health (E)-coach chronic disease management model on the rehabilitation behaviour management of patients with arteriosclerosis obliterans (ASO).
You-Yuan Yuan   +8 more
doaj   +3 more sources

Orthotopic kidney transplantation from a living renal donor after interventional therapy for bilateral arteriosclerosis obliterans of the iliac arteries: A case report and literature review

open access: yesIJU Case Reports, 2023
Introduction Orthotopic kidney transplantation is an option when heterotopic kidney transplantation into the iliac fossa is inappropriate. We report a case of orthotopic kidney transplantation following stenting of both external iliac arteries to treat ...
Takehiro Ohyama   +4 more
doaj   +2 more sources

Potential Mechanisms of Yanghe Decoction in the Treatment of Soft Tissue Sarcoma and Arteriosclerosis Obliterans Based on Network Pharmacology

open access: yesChinese Medicine and Natural Products, 2022
Objective The objective of this study was to investigate potential mechanisms of Yanghe Decoction ( , YHD) in treating soft tissue sarcoma (STS) and arteriosclerosis obliterans (ASO) based on the use of network ...
Yiran Zhai   +5 more
doaj   +2 more sources

HSPB1 Regulates Autophagy and Apoptosis in Vascular Smooth Muscle Cells in Arteriosclerosis Obliterans

open access: yesCardiovascular Therapeutics, 2022
Objective. Small heat shock protein-1 (HSPB1) is a small heat shock protein that participates in many cellular processes and alleviates stress-induced cell injury.
Keqin Chen   +8 more
doaj   +2 more sources

Clinical Significance of Endothelin-1 And C Reaction Protein in Restenosis After the Intervention of Lower Extremity Arteriosclerosis Obliterans

open access: yesJournal of Investigative Surgery, 2021
Objective This study aims to investigate the role of endothelin-1 (ET-1) and C-reactive protein (CRP) in restenosis after intervention of lower extremity arteriosclerosis obliterans. Methods The present prospective observational study included a total of
Weishuai Lian   +5 more
doaj   +2 more sources

Microarray Expression Profile and Bioinformatic Analysis of Circular RNA in Human Arteriosclerosis Obliterans

open access: yesPharmacogenomics and Personalized Medicine, 2023
Yu Zhou,1,* Huoying Cai,1,* Lin Huang,1,* Mingshan Wang,1 Ruiming Liu,2 Siwen Wang,1 Yuansen Qin,1 Chen Yao,1 Zuojun Hu1 1Division of Vascular Surgery, National-Guangdong Joint Engineering Laboratory for Diagnosis and Treatment of Vascular ...
Zhou Y   +8 more
doaj   +2 more sources

Predictive Value of Contrast-Enhanced Ultrasound in Chemical Lumbar Sympathectomy for End-Stage Arteriosclerosis Obliterans of the Lower Extremities [PDF]

open access: goldPain and Therapy, 2022
Introduction The therapeutic effect of chemical lumbar sympathectomy (CLS) on ischemic diseases of the lower limbs varies greatly among individuals. The time to peak (TTP) response in contrast-enhanced ultrasound (CEUS) can reflect the perfusion disorder
Yuehua Wu   +5 more
semanticscholar   +2 more sources

Venous thrombosis and arteriosclerosis obliterans of lower extremities in a very severe patient with 2019 novel coronavirus disease: a case report [PDF]

open access: bronzeJournal of Thrombosis and Thrombolysis, 2020
The outbreak of 2019 novel coronavirus disease (COVID-19) began since early December 2019, and has been declared as a public health emergency by the World Health Organization.
Bo Zhou, J. She, Yadan Wang, Xiancang Ma
semanticscholar   +2 more sources

The clinical significance of serum HMGB1 in patients with lower extremity arteriosclerosis obliterans after interventional vascular restenosis

open access: yesFrontiers in Surgery, 2023
ObjectiveThis study explored the correlation between serum HMGB1 levels and postoperative vascular restenosis in patients with lower extremity arteriosclerosis obliterans (LEASO).MethodsA total of 362 patients LEASO who received vascular intervention ...
Bo Yang, Zhang Xiaping, Zhang Xiaping
doaj   +2 more sources

Clinical study of hepatocyte growth factor in the treatment of diabetic lower limb arteriosclerosis obliterans

open access: diamondVascular Investigation and Therapy, 2022
OBJECTIVE: The objective of this study was to investigate the safety and efficacy of hepatocyte growth factor (HGF) gene therapy in the patients with diabetic lower limb arteriosclerosis obliterans, provide theoretical support for better coordination of ...
Ling Zhang   +5 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy